Press Releases.

May 30, 2022 1:46pm

Volition Achieves CE Mark for Nu.Q® NETs Test

May 11, 2022 9:30am

VolitionRx Limited Announces First Quarter 2022 Financial Results and Business Update

May 06, 2022 10:35am

VolitionRx Limited Schedules First Quarter 2022 Earnings Conference Call and Business Update

May 05, 2022 12:59pm

VolitionRx Limited to Host Capital Markets Day on Friday May 13.

Apr 25, 2022 1:11pm

Volition launches its Nu.Q®Vet Cancer Test in Asia through its appointed distributor SAGE Healthcare

Apr 06, 2022 1:00pm

Volition appoints Sharon Ballesteros as U.S. Head of Quality and Development Process

Mar 30, 2022 9:10pm

VolitionRx Limited Announces Full Fiscal Year 2021 Financial Results and Business Update

Mar 29, 2022 1:00pm

Volition Signs Exclusive $28 million License and Supply Agreement with Heska Corporation to Distribute Nu.Q® Vet Cancer Screening Test at the Point of Care

Mar 28, 2022 9:25pm

VolitionRx Limited Schedules Full Fiscal Year 2021 Earnings Conference Call and Business Update

Jan 20, 2022 1:47pm

Volition presents study data at ASCO GI 2022 on circulating nucleosomes for the detection of colorectal cancer and high-risk advanced adenomas

Dec 16, 2021 1:30pm

Volition Executes its First Supply and Licensing Contract for its Nu.Q® Vet Cancer Screening Test in Asia

Nov 10, 2021 9:15pm

VolitionRx Limited Announces Third Quarter 2021 Financial Results and Business Update